← Open Payments lookup

ROBYN HUDSON: Open Payments

NPI 1528660552 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$760 in 41 payments from 11 companies in 2025. Trend: 2023 $380 · 2024 $758 · 2025 $760

Food & beverage: $760
CompanyPaymentsAmount
Novo Nordisk Inc11$229
ABBVIE INC.10$181
AstraZeneca Pharmaceuticals LP5$80
Lilly USA, LLC3$52
GlaxoSmithKline, LLC.3$52
UCB, Inc.2$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$40
Phathom Pharmaceuticals, Inc.2$32
Janssen Pharmaceuticals, Inc1$20
Exact Sciences Corporation1$18

Products named: Ozempic, VRAYLAR, AIRSUPRA, MOUNJARO, XIFAXAN, TRELEGY ELLIPTA, VOQUEZNA, Fintepla.

Industry payments across MS — which companies pay providers there.